Search Results - "Loebel, AD"

Duration of psychosis and outcome in first-episode schizophrenia by Loebel, A D, Lieberman, J A, Alvir, J M, Mayerhoff, D I, Geisler, S H, Szymanski, S R

“…This study was undertaken to assess the potential effect of duration of untreated illness on outcome in a group of first-episode schizophrenic patients…”
Get more information

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study by Vieta, E., Ramey, T., Keller, D., English, PA, Loebel, AD, Miceli, J.

“…This 12-week, double-blind, two-part study in 438 adults with bipolar-associated acute mania began with a 3-week period comparing ziprasidone (80—160 mg/day)…”
Get full text

Effect of initial ziprasidone dose on length of therapy in schizophrenia by Joyce, Amie T., Harrison, David J., Loebel, Antony D., Carter, Chureen T., Ollendorf, Daniel A.

“…To examine the effects of initial ziprasidone dose on discontinuation rates, using retrospective integrated medical and pharmacy claims data. Patients ≥ 18…”
Get full text

Impact of atypical antipsychotics on outcomes of care in schizophrenia by Joyce, Amie T, Harrison, David J, Loebel, Antony D, Ollendorf, Daniel A

“…To compare persistence, compliance, and psychiatric treatment costs in patients who were initiated on atypical antipsychotics. Medical and pharmacy claims data…”
Get full text

Dopaminergic mechanisms in idiopathic and drug-induced psychoses by Lieberman, J A, Kinon, B J, Loebel, A D

“…Stimulant drugs such as cocaine and amphetamine are among the most commonly abused substances by schizophrenic patients. This may be due in part to aspects of…”
Get full text

The deficit state in first-episode schizophrenia by Mayerhoff, D I, Loebel, A D, Alvir, J M, Szymanski, S R, Geisler, S H, Borenstein, M, Lieberman, J A

“…The prevalence, clinical correlates, and outcome of the deficit syndrome were determined for 70 patients ascertained in their first episode of schizophrenia…”
Get more information

Atypical antipsychotics in the managed care era by Loebel, A D, Botts, S R, Feldman, B I

“…Over the past decade, a new class of atypical antipsychotic drugs has been developed for the treatment of schizophrenia and related conditions. This new…”
Get full text

Early placebo response in anxious and depressed patients by LOEBEL, A. D, HYDE, T. S, DUNNER, D. L

“…Specific subgroups of anxiety disorder patients (N = 130) and depression patients (N = 105), defined according to DSM-III criteria, were given 1 week of…”
Get full text

Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia by Chakos, M H, Mayerhoff, D I, Loebel, A D, Alvir, J M, Lieberman, J A

“…The incidence and correlates of extrapyramidal symptoms (EPS) in neuroleptic treatment of schizophrenic patients have been reported for chronic patients but…”
Get more information